Global Gastroparesis Drugs Market Growth 2023-2029

Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.

LPI (LP Information)' newest research report, the “Gastroparesis Drugs Industry Forecast” looks at past sales and reviews total world Gastroparesis Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastroparesis Drugs sales for 2023 through 2029. With Gastroparesis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastroparesis Drugs industry.

This Insight Report provides a comprehensive analysis of the global Gastroparesis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastroparesis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gastroparesis Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastroparesis Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastroparesis Drugs.

The global Gastroparesis Drugs market size is projected to grow from US$ 5535.9 million in 2022 to US$ 7513.8 million in 2029; it is expected to grow at a CAGR of 7513.8 from 2023 to 2029.

North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.

Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastroparesis Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Prokinetic Agents
    Antiemetic Agents
    Others

Segmentation by application
    Diabetic Gastroparesis
    Idiopathic Gastroparesis

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Sumitomo
    Cadila Pharmaceuticals
    Sanofi
    Teva
    Johnson & Johnson
    Pfizer
    Kyowa Kirin Pharmaceuticals
    Hanmi Pharm
    Ani Pharmaceuticals

Key Questions Addressed in this Report
What is the 10-year outlook for the global Gastroparesis Drugs market?
What factors are driving Gastroparesis Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gastroparesis Drugs market opportunities vary by end market size?
How does Gastroparesis Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Gastroparesis Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Gastroparesis Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Prokinetic Agents
    Table 4. Major Players of Antiemetic Agents
    Table 5. Major Players of Others
    Table 6. Global Gastroparesis Drugs Sales by Type (2018-2023) & (Kg)
    Table 7. Global Gastroparesis Drugs Sales Market Share by Type (2018-2023)
    Table 8. Global Gastroparesis Drugs Revenue by Type (2018-2023) & ($ million)
    Table 9. Global Gastroparesis Drugs Revenue Market Share by Type (2018-2023)
    Table 10. Global Gastroparesis Drugs Sale Price by Type (2018-2023) & (US$/mg)
    Table 11. Global Gastroparesis Drugs Sales by Application (2018-2023) & (Kg)
    Table 12. Global Gastroparesis Drugs Sales Market Share by Application (2018-2023)
    Table 13. Global Gastroparesis Drugs Revenue by Application (2018-2023)
    Table 14. Global Gastroparesis Drugs Revenue Market Share by Application (2018-2023)
    Table 15. Global Gastroparesis Drugs Sale Price by Application (2018-2023) & (US$/mg)
    Table 16. Global Gastroparesis Drugs Sales by Company (2018-2023) & (Kg)
    Table 17. Global Gastroparesis Drugs Sales Market Share by Company (2018-2023)
    Table 18. Global Gastroparesis Drugs Revenue by Company (2018-2023) ($ Millions)
    Table 19. Global Gastroparesis Drugs Revenue Market Share by Company (2018-2023)
    Table 20. Global Gastroparesis Drugs Sale Price by Company (2018-2023) & (US$/mg)
    Table 21. Key Manufacturers Gastroparesis Drugs Producing Area Distribution and Sales Area
    Table 22. Players Gastroparesis Drugs Products Offered
    Table 23. Gastroparesis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Gastroparesis Drugs Sales by Geographic Region (2018-2023) & (Kg)
    Table 27. Global Gastroparesis Drugs Sales Market Share Geographic Region (2018-2023)
    Table 28. Global Gastroparesis Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 29. Global Gastroparesis Drugs Revenue Market Share by Geographic Region (2018-2023)
    Table 30. Global Gastroparesis Drugs Sales by Country/Region (2018-2023) & (Kg)
    Table 31. Global Gastroparesis Drugs Sales Market Share by Country/Region (2018-2023)
    Table 32. Global Gastroparesis Drugs Revenue by Country/Region (2018-2023) & ($ millions)
    Table 33. Global Gastroparesis Drugs Revenue Market Share by Country/Region (2018-2023)
    Table 34. Americas Gastroparesis Drugs Sales by Country (2018-2023) & (Kg)
    Table 35. Americas Gastroparesis Drugs Sales Market Share by Country (2018-2023)
    Table 36. Americas Gastroparesis Drugs Revenue by Country (2018-2023) & ($ Millions)
    Table 37. Americas Gastroparesis Drugs Revenue Market Share by Country (2018-2023)
    Table 38. Americas Gastroparesis Drugs Sales by Type (2018-2023) & (Kg)
    Table 39. Americas Gastroparesis Drugs Sales by Application (2018-2023) & (Kg)
    Table 40. APAC Gastroparesis Drugs Sales by Region (2018-2023) & (Kg)
    Table 41. APAC Gastroparesis Drugs Sales Market Share by Region (2018-2023)
    Table 42. APAC Gastroparesis Drugs Revenue by Region (2018-2023) & ($ Millions)
    Table 43. APAC Gastroparesis Drugs Revenue Market Share by Region (2018-2023)
    Table 44. APAC Gastroparesis Drugs Sales by Type (2018-2023) & (Kg)
    Table 45. APAC Gastroparesis Drugs Sales by Application (2018-2023) & (Kg)
    Table 46. Europe Gastroparesis Drugs Sales by Country (2018-2023) & (Kg)
    Table 47. Europe Gastroparesis Drugs Sales Market Share by Country (2018-2023)
    Table 48. Europe Gastroparesis Drugs Revenue by Country (2018-2023) & ($ Millions)
    Table 49. Europe Gastroparesis Drugs Revenue Market Share by Country (2018-2023)
    Table 50. Europe Gastroparesis Drugs Sales by Type (2018-2023) & (Kg)
    Table 51. Europe Gastroparesis Drugs Sales by Application (2018-2023) & (Kg)
    Table 52. Middle East & Africa Gastroparesis Drugs Sales by Country (2018-2023) & (Kg)
    Table 53. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country (2018-2023)
    Table 54. Middle East & Africa Gastroparesis Drugs Revenue by Country (2018-2023) & ($ Millions)
    Table 55. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country (2018-2023)
    Table 56. Middle East & Africa Gastroparesis Drugs Sales by Type (2018-2023) & (Kg)
    Table 57. Middle East & Africa Gastroparesis Drugs Sales by Application (2018-2023) & (Kg)
    Table 58. Key Market Drivers & Growth Opportunities of Gastroparesis Drugs
    Table 59. Key Market Challenges & Risks of Gastroparesis Drugs
    Table 60. Key Industry Trends of Gastroparesis Drugs
    Table 61. Gastroparesis Drugs Raw Material
    Table 62. Key Suppliers of Raw Materials
    Table 63. Gastroparesis Drugs Distributors List
    Table 64. Gastroparesis Drugs Customer List
    Table 65. Global Gastroparesis Drugs Sales Forecast by Region (2024-2029) & (Kg)
    Table 66. Global Gastroparesis Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 67. Americas Gastroparesis Drugs Sales Forecast by Country (2024-2029) & (Kg)
    Table 68. Americas Gastroparesis Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 69. APAC Gastroparesis Drugs Sales Forecast by Region (2024-2029) & (Kg)
    Table 70. APAC Gastroparesis Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 71. Europe Gastroparesis Drugs Sales Forecast by Country (2024-2029) & (Kg)
    Table 72. Europe Gastroparesis Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 73. Middle East & Africa Gastroparesis Drugs Sales Forecast by Country (2024-2029) & (Kg)
    Table 74. Middle East & Africa Gastroparesis Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 75. Global Gastroparesis Drugs Sales Forecast by Type (2024-2029) & (Kg)
    Table 76. Global Gastroparesis Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 77. Global Gastroparesis Drugs Sales Forecast by Application (2024-2029) & (Kg)
    Table 78. Global Gastroparesis Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 79. Sumitomo Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 80. Sumitomo Gastroparesis Drugs Product Portfolios and Specifications
    Table 81. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 82. Sumitomo Main Business
    Table 83. Sumitomo Latest Developments
    Table 84. Cadila Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 85. Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
    Table 86. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 87. Cadila Pharmaceuticals Main Business
    Table 88. Cadila Pharmaceuticals Latest Developments
    Table 89. Sanofi Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 90. Sanofi Gastroparesis Drugs Product Portfolios and Specifications
    Table 91. Sanofi Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 92. Sanofi Main Business
    Table 93. Sanofi Latest Developments
    Table 94. Teva Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 95. Teva Gastroparesis Drugs Product Portfolios and Specifications
    Table 96. Teva Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 97. Teva Main Business
    Table 98. Teva Latest Developments
    Table 99. Johnson & Johnson Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 100. Johnson & Johnson Gastroparesis Drugs Product Portfolios and Specifications
    Table 101. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 102. Johnson & Johnson Main Business
    Table 103. Johnson & Johnson Latest Developments
    Table 104. Pfizer Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 105. Pfizer Gastroparesis Drugs Product Portfolios and Specifications
    Table 106. Pfizer Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 107. Pfizer Main Business
    Table 108. Pfizer Latest Developments
    Table 109. Kyowa Kirin Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 110. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
    Table 111. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 112. Kyowa Kirin Pharmaceuticals Main Business
    Table 113. Kyowa Kirin Pharmaceuticals Latest Developments
    Table 114. Hanmi Pharm Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 115. Hanmi Pharm Gastroparesis Drugs Product Portfolios and Specifications
    Table 116. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 117. Hanmi Pharm Main Business
    Table 118. Hanmi Pharm Latest Developments
    Table 119. Ani Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 120. Ani Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
    Table 121. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2018-2023)
    Table 122. Ani Pharmaceuticals Main Business
    Table 123. Ani Pharmaceuticals Latest Developments
List of Figures
    Figure 1. Picture of Gastroparesis Drugs
    Figure 2. Gastroparesis Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Gastroparesis Drugs Sales Growth Rate 2018-2029 (Kg)
    Figure 7. Global Gastroparesis Drugs Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Gastroparesis Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Prokinetic Agents
    Figure 10. Product Picture of Antiemetic Agents
    Figure 11. Product Picture of Others
    Figure 12. Global Gastroparesis Drugs Sales Market Share by Type in 2022
    Figure 13. Global Gastroparesis Drugs Revenue Market Share by Type (2018-2023)
    Figure 14. Gastroparesis Drugs Consumed in Diabetic Gastroparesis
    Figure 15. Global Gastroparesis Drugs Market: Diabetic Gastroparesis (2018-2023) & (Kg)
    Figure 16. Gastroparesis Drugs Consumed in Idiopathic Gastroparesis
    Figure 17. Global Gastroparesis Drugs Market: Idiopathic Gastroparesis (2018-2023) & (Kg)
    Figure 18. Global Gastroparesis Drugs Sales Market Share by Application (2022)
    Figure 19. Global Gastroparesis Drugs Revenue Market Share by Application in 2022
    Figure 20. Gastroparesis Drugs Sales Market by Company in 2022 (Kg)
    Figure 21. Global Gastroparesis Drugs Sales Market Share by Company in 2022
    Figure 22. Gastroparesis Drugs Revenue Market by Company in 2022 ($ Million)
    Figure 23. Global Gastroparesis Drugs Revenue Market Share by Company in 2022
    Figure 24. Global Gastroparesis Drugs Sales Market Share by Geographic Region (2018-2023)
    Figure 25. Global Gastroparesis Drugs Revenue Market Share by Geographic Region in 2022
    Figure 26. Americas Gastroparesis Drugs Sales 2018-2023 (Kg)
    Figure 27. Americas Gastroparesis Drugs Revenue 2018-2023 ($ Millions)
    Figure 28. APAC Gastroparesis Drugs Sales 2018-2023 (Kg)
    Figure 29. APAC Gastroparesis Drugs Revenue 2018-2023 ($ Millions)
    Figure 30. Europe Gastroparesis Drugs Sales 2018-2023 (Kg)
    Figure 31. Europe Gastroparesis Drugs Revenue 2018-2023 ($ Millions)
    Figure 32. Middle East & Africa Gastroparesis Drugs Sales 2018-2023 (Kg)
    Figure 33. Middle East & Africa Gastroparesis Drugs Revenue 2018-2023 ($ Millions)
    Figure 34. Americas Gastroparesis Drugs Sales Market Share by Country in 2022
    Figure 35. Americas Gastroparesis Drugs Revenue Market Share by Country in 2022
    Figure 36. Americas Gastroparesis Drugs Sales Market Share by Type (2018-2023)
    Figure 37. Americas Gastroparesis Drugs Sales Market Share by Application (2018-2023)
    Figure 38. United States Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 39. Canada Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Mexico Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Brazil Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 42. APAC Gastroparesis Drugs Sales Market Share by Region in 2022
    Figure 43. APAC Gastroparesis Drugs Revenue Market Share by Regions in 2022
    Figure 44. APAC Gastroparesis Drugs Sales Market Share by Type (2018-2023)
    Figure 45. APAC Gastroparesis Drugs Sales Market Share by Application (2018-2023)
    Figure 46. China Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 47. Japan Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 48. South Korea Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 49. Southeast Asia Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 50. India Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 51. Australia Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 52. China Taiwan Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 53. Europe Gastroparesis Drugs Sales Market Share by Country in 2022
    Figure 54. Europe Gastroparesis Drugs Revenue Market Share by Country in 2022
    Figure 55. Europe Gastroparesis Drugs Sales Market Share by Type (2018-2023)
    Figure 56. Europe Gastroparesis Drugs Sales Market Share by Application (2018-2023)
    Figure 57. Germany Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 58. France Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 59. UK Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 60. Italy Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Russia Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country in 2022
    Figure 63. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country in 2022
    Figure 64. Middle East & Africa Gastroparesis Drugs Sales Market Share by Type (2018-2023)
    Figure 65. Middle East & Africa Gastroparesis Drugs Sales Market Share by Application (2018-2023)
    Figure 66. Egypt Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 67. South Africa Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 68. Israel Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Turkey Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 70. GCC Country Gastroparesis Drugs Revenue Growth 2018-2023 ($ Millions)
    Figure 71. Manufacturing Cost Structure Analysis of Gastroparesis Drugs in 2022
    Figure 72. Manufacturing Process Analysis of Gastroparesis Drugs
    Figure 73. Industry Chain Structure of Gastroparesis Drugs
    Figure 74. Channels of Distribution
    Figure 75. Global Gastroparesis Drugs Sales Market Forecast by Region (2024-2029)
    Figure 76. Global Gastroparesis Drugs Revenue Market Share Forecast by Region (2024-2029)
    Figure 77. Global Gastroparesis Drugs Sales Market Share Forecast by Type (2024-2029)
    Figure 78. Global Gastroparesis Drugs Revenue Market Share Forecast by Type (2024-2029)
    Figure 79. Global Gastroparesis Drugs Sales Market Share Forecast by Application (2024-2029)
    Figure 80. Global Gastroparesis Drugs Revenue Market Share Forecast by Application (2024-2029)

Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape